Zhangzhou Pientzehuang Pharmaceutical Co Ltd banner

Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436

Watchlist Manager
Zhangzhou Pientzehuang Pharmaceutical Co Ltd Logo
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Watchlist
Price: 143.55 CNY 3.04% Market Closed
Market Cap: ¥86.6B

Zhangzhou Pientzehuang Pharmaceutical Co Ltd
Long-Term Investments

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Zhangzhou Pientzehuang Pharmaceutical Co Ltd
Long-Term Investments Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Investments CAGR 3Y CAGR 5Y CAGR 10Y
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Long-Term Investments
¥1.4B
CAGR 3-Years
26%
CAGR 5-Years
6%
CAGR 10-Years
9%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Long-Term Investments
¥772.5m
CAGR 3-Years
6%
CAGR 5-Years
94%
CAGR 10-Years
N/A
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Long-Term Investments
¥2B
CAGR 3-Years
10%
CAGR 5-Years
6%
CAGR 10-Years
40%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Long-Term Investments
¥13.6B
CAGR 3-Years
5%
CAGR 5-Years
60%
CAGR 10-Years
58%
Zhejiang Nhu Co Ltd
SZSE:002001
Long-Term Investments
¥1.4B
CAGR 3-Years
47%
CAGR 5-Years
31%
CAGR 10-Years
32%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Long-Term Investments
¥1.1m
CAGR 3-Years
-16%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
No Stocks Found

Zhangzhou Pientzehuang Pharmaceutical Co Ltd
Glance View

Market Cap
86.6B CNY
Industry
Pharmaceuticals

Zhangzhou Pientzehuang Pharmaceutical Co. Ltd., nestled in the heart of Fujian Province, China, is a firm steeped in history and tradition, yet thriving in today’s modern pharmaceutical landscape. The company is best known for its signature product, Pientzehuang Pills, a centuries-old traditional Chinese medicine believed to offer hepatoprotective and detoxifying properties. Rooted in ancient formulations, Pientzehuang Pills are celebrated for their efficacy in addressing liver ailments and enhancing overall vitality. This has secured their place as a staple in Chinese households, maintaining cultural resonance while appealing to a broader audience through the global rise in demand for alternative medicine. The firm operates with a delicate balance, integrating traditional Chinese medicine practices with increasingly sophisticated production technologies to ensure quality consistency and scalability. Zhangzhou Pientzehuang leverages its brand heritage and expertise in traditional herbal remedies to drive revenue. The company has adeptly positioned itself within both domestic and international markets, capitalizing on the growing interest in holistic health approaches. By focusing on research and development, the company continues to innovate, expanding its product line to include health supplements and preventive solutions that cater to modern health challenges. Its strategic distribution channels, including hospitals, pharmacies, and online platforms, enable broad market penetration, ensuring robust sales growth. This dual strategy of preserving the traditional while embracing the modern allows the company to keep its legacy relevant in a competitive pharmaceutical industry, thereby securing its stronghold in the market and ensuring sustained financial performance.

Intrinsic Value
87.85 CNY
Overvaluation 39%
Intrinsic Value
Price ¥143.55

See Also

What is Zhangzhou Pientzehuang Pharmaceutical Co Ltd's Long-Term Investments?
Long-Term Investments
1.4B CNY

Based on the financial report for Sep 30, 2025, Zhangzhou Pientzehuang Pharmaceutical Co Ltd's Long-Term Investments amounts to 1.4B CNY.

What is Zhangzhou Pientzehuang Pharmaceutical Co Ltd's Long-Term Investments growth rate?
Long-Term Investments CAGR 10Y
9%

Over the last year, the Long-Term Investments growth was 78%. The average annual Long-Term Investments growth rates for Zhangzhou Pientzehuang Pharmaceutical Co Ltd have been 26% over the past three years , 6% over the past five years , and 9% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett